Comparative Pharmacokinetics and Food-Effect Bioavailability of a Sprinkle Formulation of Lubiprostone After Oral Administration in Healthy Volunteers

Trial Profile

Comparative Pharmacokinetics and Food-Effect Bioavailability of a Sprinkle Formulation of Lubiprostone After Oral Administration in Healthy Volunteers

Completed
Phase of Trial: Phase III

Latest Information Update: 10 May 2017

At a glance

  • Drugs Lubiprostone (Primary)
  • Indications Constipation; Irritable bowel syndrome
  • Focus Pharmacokinetics
  • Sponsors Sucampo AG
  • Most Recent Events

    • 08 Mar 2017 Top line results from this trial will be available in Q1 2017, according to a Sucampo Pharmaceuticals media release.
    • 08 Mar 2017 Status changed from active, no longer recruiting to completed, according to a Sucampo Pharmaceuticals media release.
    • 09 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top